Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation. Insights From the Ontario ICD Database

Journal of the American College of Cardiology

Volumn 55, Issue 8, 2010, Pages 774-782

  Lee, Douglas S ^a,b   Krahn, Andrew D ^f   Healey, Jeffrey S ^e   Birnie, David ^g   Crystal, Eugene ^c   Dorian, Paul ^d   Simpson, Christopher S ^h   Khaykin, Yaariv ⁱ   Cameron, Douglas ^b   Janmohamed, Amir ^j   Yee, Raymond ^f   Austin, Peter C ^a   Chen, Zhongliang ^a   Hardy, Judy ^a   Tu, Jack V ^a,c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e HAMILTON HEALTH SCIENCES   (Canada)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

^g UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^h KINGSTON GENERAL HOSPITAL   (Canada)

ⁱ SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^j Rouge Valley Health System   (Canada)

more..

Author keywords

complications; implantable defibrillators; mortality; outcomes research; quality of care

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CANADA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CLINICAL TRIAL; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY PERFORATION; DEFIBRILLATOR; DEVICE INFECTION; DIAPHRAGM DISEASE; DRUG USE; EMBOLISM; EROSION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HUMAN; HYPOTENSION; IMPLANT REGISTRY; IMPLANTATION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LEFT VENTRICULAR ENDSYSTOLIC DIMENSION; LONGITUDINAL STUDY; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL PERFORATION; PERFORATION; PERIPHERAL NERVE INJURY; PNEUMOTHORAX; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; RISK; SECONDARY PREVENTION; SEPSIS; SEX DIFFERENCE; SKIN EROSION; STROKE; SUBCLAVIAN VEIN; THROMBUS; TREATMENT OUTCOME; VEIN THROMBOSIS; WOUND INFECTION;

AGED; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 76449116531     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.11.029     Document Type: Article

References (26)

1. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
4. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
5. Lee D.S., Tu J.V., Austin P.C., et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 49 (2007) 2408-2415
6. Al-Khatib S.M., Anstrom K.J., Eisenstein E.L., et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 142 (2005) 593-600
7. Lee D.S., Birnie D., Cameron D., et al. Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario. Heart Rhythm 5 (2008) 1250-1256
8. Tu J.V., Willison D.J., Silver F.L., et al. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 350 (2004) 1414-1421
9. Kron J., Herre J., Renfroe E.G., et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 141 (2001) 92-98
10. Gould P.A., and Krahn A.D. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 295 (2006) 1907-1911
11. Gradaus R., Block M., Brachmann J., et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol 26 (2003) 1511-1518
12. Alter P., Waldhans S., Plachta E., Moosdorf R., and Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 28 (2005) 926-932
13. Gold M.R., Peters R.W., Johnson J.W., Shorofsky S.R., and World-Wide Jewel Investigators. Complications associated with pectoral implantation of cardioverter defibrillators. Pacing Clin Electrophysiol 20 (1997) 208-211
14. Peterson P.N., Daugherty S.L., Wang Y., et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 119 (2009) 1078-1084
15. Anderson K.P. Estimates of implantable cardioverter-defibrillator complications: caveat emptor. Circulation 119 (2009) 1069-1071
16. Gibbs J.L., Monro J.L., Cunningham D., and Rickards A. Survival after surgery or therapeutic catheterisation for congenital heart disease in children in the United Kingdom: analysis of the central cardiac audit database for 2000-1. BMJ 328 (2004) 611
17. Al-Khatib S.M., Greiner M.A., Peterson E.D., Hernandez A.F., Schulman K.A., and Curtis L.H. Patient and implanting physician factors associated with mortality and complications following implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol 1 (2008) 240-249
18. Reynolds M.R., Cohen D.J., Kugelmass A.D., et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47 (2006) 2493-2497
19. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K., and Bates D.W. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 138 (2003) 161-167
20. Tischenko A., Gula L.J., Yee R., Klein G.J., Skanes A.C., and Krahn A.D. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Am Heart J 158 (2009) 252-256
21. Tolosana J.M., Berne P., Mont L., et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin?. A prospective randomized trial. Eur Heart J 30 (2009) 1880-1884
22. Lee D.S., Austin P.C., Stukel T.A., et al. "Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med 122 (2009) 162-169
23. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008) 1009-1017
24. Sesselberg H.W., Moss A.J., McNitt S., et al., MADIT-II Research Group. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 4 (2007) 1395-1402
25. Exner D.V., Pinski S.L., Wyse D.G., et al., AVID Investigators. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 103 (2001) 2066-2071
26. Brigadeau F., Kouakam C., Klug D., et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 27 (2006) 700-707